• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Epizyme - Articles and news items

Epizyme releases additional data from Phase 1 study of tazemetostat in non-Hodgkin’s lymphoma

Industry news / 22 June 2015 / Victoria White

Epizyme has reported results from the ongoing Phase 1 trial of tazemetostat in patients with advanced B-cell non-Hodgkin’s lymphoma and solid tumours…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +